comparemela.com
Home
Live Updates
Susanne Stowasser - Breaking News
Pages:
Susanne Stowasser News Today : Breaking News, Live Updates & Top Stories | Vimarsana
New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease
InPedILD Phase III trial showed encouraging results for both primary endpoints. Full data were published in the European Respiratory Journal and presented at.
United states
Comunidad autonoma de cataluna
Kerry wycislo
Robin deterding
Boehringer ingelheim
Susanne stowasser
Boehringer ingelheim pharmaceuticals
Boehringer ingelheim pharmaceuticals inc
European respiratory society international congress
Drug administration
International congress
European respiratory society
Human pharma communications
Animal health
European medicines agency
Corporate affairs
vimarsana © 2020. All Rights Reserved.